Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space

#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a

Saved in:
Bibliographic Details
Published inERJ Open Research Vol. 6; no. 4; p. 455
Main Authors Orfanos, Sarah, El Husseini, Ibrahim, Nahass, Thomas, Radbel, Jared, Hussain, Sabiha
Format Journal Article Web Resource
LanguageEnglish
Published Lausanne European Respiratory Society Journals Ltd 01.10.2020
European Respiratory Society
Subjects
Original Research Letters
Online AccessGet full text

Cover

More Information
Summary:#COVID19-induced ARDS is partly explained by the presence of microthrombi, motivating the use of thrombolytics. This study shows that thrombolytics decrease dead space ventilation in COVID-19 ARDS patients. https://bit.ly/2GdM44a
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2312-0541
2312-0541
DOI:10.1183/23120541.00455-2020